| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/27/2010 | EP2146779A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN100584832C 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 01/26/2010 | US7652019 5,6-trimethylenepyrimidin-4-one compounds |
| 01/26/2010 | US7652018 4-[2-(3,5,5-Trimethyl-2-oxoimidazolidin-1-yl)-1,3-thiazol-4-yl]benzonitrile; 1-[4-(4-Bromophenyl)-1,3-thiazol-2-yl]-3-methylimidazolidin-2-one; contraception, fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas |
| 01/26/2010 | US7652013 Inhibitors of stearoyl-CoA desaturase |
| 01/26/2010 | US7652009 Substituted heterocycles and methods of use |
| 01/26/2010 | US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof |
| 01/26/2010 | CA2469380C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/26/2010 | CA2392630C 2-amino-5,6-dihalo-3,4-dihydroquinazolines with blood platelet reducing properties |
| 01/21/2010 | WO2010007800A1 Novel uracil compound having amide structure and salt thereof |
| 01/21/2010 | WO2010007427A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | WO2010007318A2 Novel imidazo[1,2-a]pyrimidine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | WO2010006792A1 Synthesis of cyclic amidines |
| 01/21/2010 | WO2010006496A1 Compounds of estrogen-related receptor modulators and the uses thereof |
| 01/21/2010 | WO2009115927A3 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 01/21/2010 | US20100016591 Synthesis of 4-amino-pyrimidines scaffolds |
| 01/21/2010 | US20100016338 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-arylquinolin-2-ones, a Process for their Production and their Use as Anti-inflammatory Agents |
| 01/21/2010 | US20100016318 Anthranilamide inhibitors of aurora kinase |
| 01/21/2010 | US20100016317 Hiv inhibiting 6-substituted pyrimidines |
| 01/21/2010 | US20100016281 Pyrimidine compounds as serotonin receptor modulators |
| 01/21/2010 | US20100016275 Novel compound 395 |
| 01/21/2010 | US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 01/21/2010 | US20100016252 Mannich Base N-Oxide Drugs |
| 01/21/2010 | CA2739379A1 Compounds as the estrogen-related receptor modulators and the uses thereof |
| 01/21/2010 | CA2730964A1 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
| 01/21/2010 | CA2730477A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/20/2010 | EP2144889A2 Quinazolin-oxime derivatives as hsp90 inhibitors |
| 01/20/2010 | EP2144888A1 Methods for treating cancer |
| 01/20/2010 | EP2144887A1 Dosages and methods for the treatment of cancer |
| 01/20/2010 | EP1831159B1 Tetralin and indane derivatives and uses thereof |
| 01/20/2010 | CN101631779A Aspartyl protease inhibitors containing a tricyclic ring system |
| 01/20/2010 | CN101631778A Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors |
| 01/20/2010 | CN101631777A Triol form of rosuvastatin |
| 01/20/2010 | CN100581543C Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/19/2010 | US7648975 Macrocyclic quinazoline derivatives as antiproliferative agents |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/14/2010 | WO2010005924A1 Crystalline forms of erlotinib base and erlotinib hcl |
| 01/14/2010 | WO2010004390A1 Quinazoline dione derivatives as trpa1 modulators |
| 01/14/2010 | US20100010220 Process for Preparing Amidrazones |
| 01/14/2010 | US20100010218 Synthesis of paliperidone |
| 01/14/2010 | US20100010025 Pyrimidine Derivatives |
| 01/14/2010 | US20100010024 Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension |
| 01/14/2010 | US20100010023 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/14/2010 | US20100010016 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100010003 Pyrimidine Derivatives And Their Use As Pesticides |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009958 Quinazoline derivatives |
| 01/14/2010 | US20100009956 Novel substituted pyrimidines as cysteine protease inhibitors |
| 01/14/2010 | US20100009927 Anti-Inflammatory and Anti-Allergy Extracts from Nettle |
| 01/14/2010 | US20100008874 Substituted pyrimidines, process for their production and their use as effective absorbents of uv irradiation |
| 01/14/2010 | CA2730314A1 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | CA2730226A1 Crystalline forms of erlotinib base and erlotinib hcl |
| 01/13/2010 | EP2142518A1 3,4-dihydroquinazoline derivatives |
| 01/13/2010 | EP2142517A2 Quinazoline compounds |
| 01/13/2010 | EP2142516A1 Pyrimidine hydrazide compounds as pgds inhibitors |
| 01/13/2010 | EP2142505A1 Sulfonamides and pharmaceutical compositions thereof |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN101627019A Bicyclic pyrimidinones and uses thereof |
| 01/13/2010 | CN101627018A Process for the preparation of rosuvastatin |
| 01/13/2010 | CN101627017A Process for the manufacture of a precursor of vitamin b1 |
| 01/13/2010 | CN101624377A Method for synthesizing key intermediate of rosuvastain calcium |
| 01/13/2010 | CN100579968C Quinazolinone derivatives and their use as CB agonists |
| 01/12/2010 | US7645878 Reacting an aniline derivative with an acylchloride to form an intermeidate, cyclizing the intermediate, replacing hydroxy group with a leaving group (chloride), racting the product with an amino-heterocyclic compound |
| 01/12/2010 | US7645764 Kinase inhibitors and methods for using the same |
| 01/12/2010 | US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/12/2010 | CA2403514C 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 01/12/2010 | CA2306428C 3-oxo-2(h)-1,2,4 - triazine derivatives as ligands of 5ht1a receptors |
| 01/07/2010 | WO2010002845A2 Quinazoline derivatives |
| 01/07/2010 | WO2010002262A1 High flow supramolecular compounds |
| 01/07/2010 | WO2010001042A2 Cosmetic composition, compound, and cosmetic treatment method |
| 01/07/2010 | WO2010001041A2 Cosmetic composition, cosmetic treatment method, and compound |
| 01/07/2010 | WO2010000396A1 Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use |
| 01/07/2010 | WO2009135455A3 Method for producing gemcitabine hydrochloride and intermediate products |
| 01/07/2010 | WO2009131687A3 Inhibitors of protein kinases |
| 01/07/2010 | WO2009095773A8 Novel heterocycles |
| 01/07/2010 | US20100004449 Crystalline forms of erlotinib base and erlotinib hcl |
| 01/07/2010 | US20100004448 Methods of preparing quinazolinone derivatives |
| 01/07/2010 | US20100004445 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines |
| 01/07/2010 | US20100004444 Novel Triazolo pyrimidine compounds |
| 01/07/2010 | US20100004273 Compounds And Methods For Treating Disorders Related To Glucose Metabolism |
| 01/07/2010 | US20100004271 Heterocyclic compounds as aganist for the thyroid receptor |
| 01/07/2010 | US20100004268 Optically Pure Dihydropyrimidine Compounds and Their Uses for the Preparation of a Medicament for Treatment and Prevention of Viral Diseases |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100003709 Crystal Structure of Enzyme and Uses Thereof |
| 01/07/2010 | DE102008031480A1 Salze enthaltend ein Pyrimidincarbonsäure-Derivat Salts containing a pyrimidinecarboxylic derivative |
| 01/07/2010 | CA2729733A1 Process for the preparation of substituted pyrimidine derivatives |
| 01/07/2010 | CA2726040A1 Quinazoline derivatives |
| 01/06/2010 | EP2141152A1 Compound for organic electroluminescent device and organic electroluminescent device |
| 01/06/2010 | EP2140864A2 Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods |
| 01/06/2010 | EP2140862A2 Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods |
| 01/06/2010 | EP2139869A2 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders |
| 01/06/2010 | EP2139868A2 Process for preparation of erlotinib and its pharmaceutically acceptable salts |
| 01/06/2010 | EP2139867A2 Co-crystals of cyprodinil and pyrimethanil |